Loading: 100%
pSivida Corp. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 22 (as per FY 2016)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker PSDVno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,00,61,21,82,4
datesClosing price (adj.)
13.10.20171.23
11.10.20171.24
04.10.20171.19
27.09.20171.20
20.09.20171.25
13.09.20171.26
06.09.20171.27
30.08.20171.21
23.08.20171.17
16.08.20171.08
09.08.20171.18
02.08.20171.15
26.07.20171.28
19.07.20171.38
12.07.20171.41
05.07.20171.71
27.06.20171.77
20.06.20171.83
13.06.20171.75
06.06.20172.14
30.05.20172.32
23.05.20172.16
16.05.20172.04
09.05.20171.99
02.05.20171.71
25.04.20171.73
18.04.20171.74
11.04.20171.71
04.04.20171.69
28.03.20171.80
21.03.20171.70
14.03.20171.68
07.03.20171.71
28.02.20171.75
21.02.20171.80
14.02.20171.70
07.02.20171.66
31.01.20171.76
24.01.20171.81
17.01.20171.91
10.01.20172.09
03.01.20171.77
27.12.20161.94
19.12.20161.81
12.12.20161.70
05.12.20161.72
28.11.20161.89
21.11.20161.94
14.11.20161.91
07.11.20162.07
31.10.20162.08
24.10.20162.31
17.10.20162.28
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
1.23n/a
Market Capitalisation
in million USD
42n/a
Enterprise Value
in million USD
13n/a
Common Shares Outstanding
as per Jun 30, 2016
34,172,919n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
31,623,473n/a
Average Diluted Shares Outstanding
TTM
31,623,473n/a
Index Membership
n/a
Business Summary
pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 2n/a
Gross Profit 2n/a
Operating Income -22n/a
EBITDA -21n/a
Net Profit -22n/a
Balance Sheet
Cash and Cash Equivalents 29n/a
Receivables 0n/a
Total Current Assets 30n/a
PP&E 0n/a
Total Assets 32n/a
Accounts Payable 1n/a
Current Debt 0n/a
Total Current Liabilities 5n/a
Long-Term Debt 0n/a
Total Liabilities 11n/a
Total Equity 21n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital 2n/a
Operating Cash Flow -16n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow -4n/a
Dividends Paid 0n/a
Financing Cash Flow 17n/a
Total Change in Cash -4n/a
Free Cash Flow -19n/a
Profitability Ratios
Gross Margin 100.0%n/a
Operating Margin -1,344.1%n/a
Net Profit Margin -1,330.1%n/a
Return on Equity -103.2%n/a
Return on Assets -68.2%n/a
Per Share Figures
Basic EPS -0.68n/a
Diluted EPS -0.68n/a
Sales per Share 0.05n/a
Book Value per Share 0.66n/a
FCF per Share -0.59n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -1.81n/a
Price to Sales Ratio 24.01n/a
Price to Book Value 1.86n/a
Price to Free Cash Flow -2.07n/a
Valuation Metrics
EV/EBITDA -0.63n/a
EV/Sales 8.05n/a
Book to Market Value 0.50n/a
Other Ratios
Current Ratio 588.3%n/a
Liabilities to Equity Ratio 51.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 68% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
23
5
4
2
3
27
2
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
23
5
4
2
3
27
2
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-14
-15
-14
-14
-17
-20
-23
Selling, General & Administrative
-7
-8
-7
-7
-7
-8
-9
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-7
-7
-7
-7
-10
-12
-14
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
9
-10
-10
-12
-14
6
-22
Non-Operating Income (Loss)
0
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
9
-10
-10
-12
-14
6
-22
Abnormal Gains (Losses)
0
-1
-15
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
9
-11
-25
-12
-13
6
-22
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
9
-11
-25
-12
-13
6
-22
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
9
-11
-25
-12
-13
6
-22
Minority Interest
0
0
0
0
0
0
0
Net Income
9
-11
-25
-12
-13
6
-22
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
9
-11
-25
-12
-13
6
-22
Remarks
restated on Sep 27, 2012 n/a
calculated values,
restated on Sep 27, 2013 n/a
calculated values,
restated on Sep 11, 2014 n/a
calculated values,
restated on Sep 10, 2015 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
24
15
10
18
29
29
Cash & Cash Equivalents
n/a
13
5
7
15
19
15
Short Term Investments
n/a
11
10
3
3
9
14
Accounts & Notes Receivable
n/a
1
1
1
1
1
0
Accounts Receivable, Net
n/a
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
0
0
2
1
1
0
Prepaid Expenses
n/a
0
0
2
1
1
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
25
16
12
19
30
30
Property, Plant & Equipment, Net
n/a
0
0
0
0
0
0
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
22
4
4
3
2
1
Intangible Assets
n/a
22
4
3
3
2
1
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
Total Noncurrent Assets
n/a
22
5
4
3
3
2
Total Assets
n/a
47
21
16
23
32
32
Liabilities and owners' equity
Payables & Accruals
n/a
2 1650000
1 1002000
3 2565000
2 1988000
3 3315000
5 4946000
Accounts Payable
n/a
0 328000
0 394000
1 671000
0 464000
1 744000
1 1363000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 1322000
1 608000
2 1894000
2 1524000
3 2571000
4 3583000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
3 3382000
2 2176000
1 738000
0 138000
0 33000
0 147000
Deferred Revenue
n/a
3 3212000
2 2176000
1 738000
0 138000
0 33000
0 147000
Derivatives & Hedging
n/a
0 170000
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
5 5032000
3 3178000
3 3303000
2 2126000
3 3348000
5 5093000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
5 4648000
4 3783000
5 5246000
6 5621000
6 5651000
6 5645000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
5 4635000
4 3783000
5 5246000
6 5584000
6 5596000
6 5585000
Deferred Tax Liabilities
n/a
0 13000
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 0
0 0
0 37000
0 55000
0 60000
Total Noncurrent Liabilities
n/a
5 4648000
4 3783000
5 5246000
6 5621000
6 5651000
6 5645000
Total Liabilities
n/a
10 9680000
7 6961000
9 8549000
8 7747000
9 8999000
11 10738000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
263 262927000
264 264452000
270 270438000
291 290893000
293 293089000
312 312242000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-227 -226923000
-252 -251758000
-264 -263658000
-277 -277013000
-271 -270666000
-292 -292213000
Other Equity
n/a
1 1429000
1 942000
1 920000
1 1044000
1 945000
1 852000
Equity Before Minority Interest
n/a
37 37433000
14 13636000
8 7700000
15 14924000
23 23368000
21 20881000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
37 37433000
14 13636000
8 7700000
15 14924000
23 23368000
21 20881000
Total Liabilities & Equity
n/a
47 47113000
21 20597000
16 16249000
23 22671000
32 32367000
32 31619000
Remarks restated on n/a restated on Sep 27, 2012 n/a restated on Sep 27, 2013 n/a restated on Sep 11, 2014 n/a restated on Sep 10, 2015 n/a restated on Sep 13, 2016 n/a restated on Sep 13, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
9
-9
-25
-12
-13
6
-22
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
3
3
2
1
1
1
1
Non-Cash Items
2
1
16
1
1
2
2
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-4
1
-3
1
0
1
2
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
10
-3
-9
-9
-11
10
-16
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
-2
-9
1
6
0
-7
-4
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-2
-9
1
6
0
-7
-4
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
1
10
0
5
19
0
17
Increase in Capital Stock
1
10
0
5
19
0
17
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
1
10
0
5
19
0
17
Net Cash Before Disc. Operations and FX
9
-3
-8
2
8
4
-4
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
9
-3
-8
2
8
4
-4
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
9
-3
-8
2
8
4
-4
Remarks
restated on Sep 27, 2012 n/a
calculated values,
restated on Sep 27, 2013 n/a
calculated values,
restated on Sep 11, 2014 n/a
calculated values,
restated on Sep 10, 2015 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
restated on Sep 13, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo